28. Alcoholic Liver Disease

  1. John WD McDonald Professor of Medicine2,
  2. Andrew K Burroughs Professor of Hepatology Consultant Physician/Hepatologist3,
  3. Brian G Feagan Professor of Medicine2 and
  4. M Brian Fennerty Professor of Medicine4
  1. Hélène Castel and
  2. Philippe Mathurin

Published Online: 22 JUL 2010

DOI: 10.1002/9781444314403.ch28

Evidence-Based Gastroenterology and Hepatology, Third Edition

Evidence-Based Gastroenterology and Hepatology, Third Edition

How to Cite

Castel, H. and Mathurin, P. (2010) Alcoholic Liver Disease, in Evidence-Based Gastroenterology and Hepatology, Third Edition (eds J. W. McDonald, A. K. Burroughs, B. G. Feagan and M. B. Fennerty), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444314403.ch28

Editor Information

  1. 2

    Robarts Clinical Trials, Robarts Research Unit, University of Western Ontario, London, Ontario, Canada

  2. 3

    The Royal Free Sheila Sherlock Liver Centre, Royal Free Hospital, and University College London, London, UK

  3. 4

    Oregon Health and Science University, Division of Gastroenterology and Hepatology, Portland, Oregon, USA

Author Information

  1. Department of Hepatology, Hôpital Claude Huriez, Lille, France

Publication History

  1. Published Online: 22 JUL 2010
  2. Published Print: 10 SEP 2010

ISBN Information

Print ISBN: 9781405181938

Online ISBN: 9781444314403



  • Alcoholic liver disease;
  • hepatocellular carcinoma (HCC);
  • serum procollagen III propeptide (PIIIP);
  • alcoholic liver disease (ALD);
  • Prothrombin time (PT);
  • Aspartate aminotransferase (AST) to platelet ratio index (APRI) is an accurate non-invasive marker of fibrosis;
  • Screening for hepatocellular carcinoma;
  • liver large cell dysplasia (LLCD);
  • Summary of screening in heavy drinkers;
  • severe alcoholic hepatitis (SAH)


This chapter contains sections titled:

  • Screening

  • Treatment

  • References